PAVmed Historical Balance Sheet

PAVMZ Stock

USD 0.02 0.01 47.57%

Trend analysis of PAVmed Series Z balance sheet accounts such as Cash of 18.9 M, Cash And Short Term Investments of 18.9 M, Common Stock Total Equity of 69.92 or Liabilities And Stockholders Equity of 23.6 M provides information on PAVmed Series' total assets, liabilities, and equity, which is the actual value of PAVmed Series Z to its prevalent stockholders. By breaking down trends over time using PAVmed Series balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining PAVmed Series Z latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PAVmed Series Z is a good buy for the upcoming year.

PAVmed Series Inventory

512,050

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Series Z. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About PAVmed Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of PAVmed Series Z at a specified time, usually calculated after every quarter, six months, or one year. PAVmed Series Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PAVmed Series and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PAVmed currently owns. An asset can also be divided into two categories, current and non-current.

PAVmed Series Balance Sheet Chart

At this time, PAVmed Series' Property Plant And Equipment Gross is fairly stable compared to the past year. Property Plant Equipment is likely to rise to about 836.7 K in 2024, whereas Total Assets are likely to drop slightly above 23.6 M in 2024.

Total Assets Total Current Liabilities Cash And Short Term Investments Common Stock Total Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of PAVmed Series assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PAVmed Series Z books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on PAVmed Series balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of PAVmed Series Z are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of PAVmed Series Z balance sheet. This account contains PAVmed Series investments that will expire within one year. These investments include stocks and bonds that can be liquidated by PAVmed Series Z fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Most accounts from PAVmed Series' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into PAVmed Series Z current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Series Z. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2023	2024 (projected)
Other Current Assets	3.8M	3.6M
Capital Surpluse	100.7M	105.7M

Other Current Assets Capital Surpluse

PAVmed Series balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Property Plant And Equipment Net	Property Plant And Equipment Gross	Property Plant Equipment	Short Long Term Debt Total	Long Term Debt
Total Assets		0.28	0.46	0.3	-0.58	-0.66	0.99	0.99	-0.59	0.75	-0.1	0.79	0.45	1.0	0.79	0.78	0.66	0.62	-0.55	-0.54	0.78	0.55	0.52	0.7	0.75	-0.66
Other Current Liab	0.28		0.36	-0.27	0.07	-0.44	0.24	0.24	-0.01	0.16	0.03	0.43	0.37	0.25	-0.16	-0.03	0.53	0.17	-0.12	0.1	0.19	0.56	0.56	0.15	0.46	-0.11
Total Current Liabilities	0.46	0.36		-0.69	0.44	-0.97	0.37	0.37	-0.54	0.86	-0.03	0.9	1.0	0.4	0.21	0.57	0.91	0.74	-0.61	-0.47	-0.08	0.95	0.96	0.81	0.91	-0.73
Total Stockholder Equity	0.3	-0.27	-0.69		-0.94	0.51	0.41	0.41	0.12	-0.28	0.0	-0.32	-0.7	0.38	0.47	0.1	-0.47	-0.28	0.16	0.02	0.7	-0.61	-0.64	-0.26	-0.38	0.18
Net Debt	-0.58	0.07	0.44	-0.94		-0.22	-0.67	-0.67	0.08	0.0	0.04	0.01	0.45	-0.65	-0.6	-0.31	0.18	0.07	0.04	0.13	-0.89	0.33	0.36	0.01	0.06	0.04
Retained Earnings	-0.66	-0.44	-0.97	0.51	-0.22		-0.58	-0.58	0.63	-0.92	0.06	-0.98	-0.97	-0.6	-0.35	-0.66	-0.96	-0.77	0.64	0.55	-0.16	-0.96	-0.96	-0.86	-0.98	0.76
Cash	0.99	0.24	0.37	0.41	-0.67	-0.58		1.0	-0.55	0.7	-0.09	0.73	0.36	1.0	0.8	0.77	0.58	0.55	-0.52	-0.52	0.85	0.45	0.42	0.65	0.69	-0.63
Cash And Short Term Investments	0.99	0.24	0.37	0.41	-0.67	-0.58	1.0		-0.55	0.7	-0.09	0.73	0.36	1.0	0.8	0.77	0.58	0.55	-0.52	-0.52	0.85	0.45	0.42	0.65	0.69	-0.63
Common Stock Total Equity	-0.59	-0.01	-0.54	0.12	0.08	0.63	-0.55	-0.55		-0.59	0.53	-0.67	-0.54	-0.56	-0.34	-0.33	-0.67	-0.42	0.13	0.49	-0.3	-0.63	-0.62	-0.52	-0.67	0.24
Capital Surpluse	0.75	0.16	0.86	-0.28	0.0	-0.92	0.7	0.7	-0.59		0.06	0.94	0.86	0.72	0.57	0.88	0.81	0.77	-0.78	-0.69	0.32	0.79	0.78	0.96	0.92	-0.91
Other Current Assets	-0.1	0.03	-0.03	0.0	0.04	0.06	-0.09	-0.09	0.53	0.06		-0.07	-0.03	-0.09	0.11	0.25	-0.13	0.11	-0.23	-0.45	-0.07	-0.15	-0.14	0.29	-0.1	-0.28
Other Stockholder Equity	0.79	0.43	0.9	-0.32	0.01	-0.98	0.73	0.73	-0.67	0.94	-0.07		0.9	0.75	0.48	0.74	0.94	0.76	-0.66	-0.59	0.35	0.92	0.91	0.89	0.99	-0.79
Total Liab	0.45	0.37	1.0	-0.7	0.45	-0.97	0.36	0.36	-0.54	0.86	-0.03	0.9		0.39	0.2	0.56	0.91	0.73	-0.61	-0.47	-0.09	0.95	0.96	0.8	0.91	-0.72
Total Current Assets	1.0	0.25	0.4	0.38	-0.65	-0.6	1.0	1.0	-0.56	0.72	-0.09	0.75	0.39		0.79	0.78	0.6	0.57	-0.53	-0.53	0.83	0.48	0.45	0.67	0.71	-0.64
Common Stock	0.79	-0.16	0.21	0.47	-0.6	-0.35	0.8	0.8	-0.34	0.57	0.11	0.48	0.2	0.79		0.8	0.37	0.53	-0.52	-0.57	0.54	0.21	0.17	0.57	0.39	-0.61
Accounts Payable	0.78	-0.03	0.57	0.1	-0.31	-0.66	0.77	0.77	-0.33	0.88	0.25	0.74	0.56	0.78	0.8		0.54	0.64	-0.86	-0.68	0.47	0.46	0.44	0.86	0.68	-0.92
Non Current Assets Total	0.66	0.53	0.91	-0.47	0.18	-0.96	0.58	0.58	-0.67	0.81	-0.13	0.94	0.91	0.6	0.37	0.54		0.74	-0.49	-0.49	0.14	0.98	0.97	0.77	0.94	-0.63
Non Currrent Assets Other	0.62	0.17	0.74	-0.28	0.07	-0.77	0.55	0.55	-0.42	0.77	0.11	0.76	0.73	0.57	0.53	0.64	0.74		-0.42	-0.5	0.14	0.7	0.68	0.77	0.75	-0.81
Other Assets	-0.55	-0.12	-0.61	0.16	0.04	0.64	-0.52	-0.52	0.13	-0.78	-0.23	-0.66	-0.61	-0.53	-0.52	-0.86	-0.49	-0.42		0.46	-0.23	-0.48	-0.47	-0.71	-0.62	0.81
Common Stock Shares Outstanding	-0.54	0.1	-0.47	0.02	0.13	0.55	-0.52	-0.52	0.49	-0.69	-0.45	-0.59	-0.47	-0.53	-0.57	-0.68	-0.49	-0.5	0.46		-0.29	-0.41	-0.4	-0.84	-0.54	0.56
Non Current Liabilities Total	0.78	0.19	-0.08	0.7	-0.89	-0.16	0.85	0.85	-0.3	0.32	-0.07	0.35	-0.09	0.83	0.54	0.47	0.14	0.14	-0.23	-0.29		0.03	0.01	0.29	0.33	-0.28
Property Plant And Equipment Net	0.55	0.56	0.95	-0.61	0.33	-0.96	0.45	0.45	-0.63	0.79	-0.15	0.92	0.95	0.48	0.21	0.46	0.98	0.7	-0.48	-0.41	0.03		1.0	0.73	0.93	-0.6
Property Plant And Equipment Gross	0.52	0.56	0.96	-0.64	0.36	-0.96	0.42	0.42	-0.62	0.78	-0.14	0.91	0.96	0.45	0.17	0.44	0.97	0.68	-0.47	-0.4	0.01	1.0		0.72	0.93	-0.59
Property Plant Equipment	0.7	0.15	0.81	-0.26	0.01	-0.86	0.65	0.65	-0.52	0.96	0.29	0.89	0.8	0.67	0.57	0.86	0.77	0.77	-0.71	-0.84	0.29	0.73	0.72		0.86	-0.88
Short Long Term Debt Total	0.75	0.46	0.91	-0.38	0.06	-0.98	0.69	0.69	-0.67	0.92	-0.1	0.99	0.91	0.71	0.39	0.68	0.94	0.75	-0.62	-0.54	0.33	0.93	0.93	0.86		-0.76
Long Term Debt	-0.66	-0.11	-0.73	0.18	0.04	0.76	-0.63	-0.63	0.24	-0.91	-0.28	-0.79	-0.72	-0.64	-0.61	-0.92	-0.63	-0.81	0.81	0.56	-0.28	-0.6	-0.59	-0.88	-0.76

Click cells to compare fundamentals

PAVmed Series Account Relationship Matchups

PAVmed Series balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.2M	19.8M	87.0M	54.0M	33.1M	23.6M
Other Current Liab	1.4M	(15.0M)	4.3M	3.7M	6.6M	7.0M
Total Current Liabilities	11.9M	20.0M	7.6M	41.2M	54.2M	56.9M
Total Stockholder Equity	(3.8M)	1.9M	61.7M	(9.7M)	(53.8M)	(51.1M)
Net Debt	1.9M	(2.3M)	(77.3M)	(3.1M)	29.1M	30.5M
Retained Earnings	(53.7M)	(88.3M)	(138.9M)	(228.2M)	(294.4M)	(279.7M)
Cash	6.2M	17.3M	77.3M	39.7M	19.6M	18.9M
Cash And Short Term Investments	6.2M	17.3M	77.3M	39.7M	19.6M	18.9M
Liabilities And Stockholders Equity	7.2M	19.8M	87.0M	54.0M	33.1M	23.6M
Capital Surpluse	14.0M	32.6M	47.6M	87.6M	100.7M	105.7M
Other Current Assets	328.3B	1.7M	5.2M	3.9M	3.8M	3.6M
Other Stockholder Equity	47.6M	87.6M	198.1M	215.9M	237.6M	249.5M
Total Liab	11.9M	20.3M	7.6M	43.0M	57.1M	60.0M
Total Current Assets	6.5M	18.9M	82.6M	43.9M	24.5M	20.8M
Common Stock	40.5K	64K	86K	95K	9K	8.6K
Accounts Payable	2.4M	3.0M	3.3M	2.7M	1.8M	2.1M
Non Current Assets Total	692.9K	837K	4.3M	10.1M	8.6M	9.1M
Common Stock Shares Outstanding	2.0M	3.2M	5.2M	5.9M	7.2M	7.6M
Non Current Liabilities Total	10.5M	300K	4.3B	1.8M	3.0M	2.8M
Short Long Term Debt Total	7.9M	8.1M	15.0M	36.6M	48.7M	51.2M
Net Invested Capital	2.0M	14.3M	59.2M	21.3M	(12.6M)	(12.0M)
Net Working Capital	(5.3M)	(1.0M)	75.1M	2.7M	(29.7M)	(28.2M)
Capital Stock	2.3M	2.6M	2.5M	2.8M	3.0M	2.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PAVmed Historical Balance Sheet

PAVmed Series Inventory

512,050

About PAVmed Balance Sheet Analysis

PAVmed Series Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash And Short Term Investments

Common Stock Total Equity

PAVmed Series balance sheet Correlations

PAVmed Series Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PAVmed Series balance sheet Accounts

Also Currently Popular

Additional Tools for PAVmed Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Short Long Term Debt Total	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Total Current Liabilities
Property Plant And Equipment Gross	- 0.96	Retained Earnings
Property Plant And Equipment Net	- 0.96	Retained Earnings